Search - tctmd.com

Displaying 341 - 360 of 372

Sort: Relevancy | Date

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Conference News

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

November 13, 2011

News Conference News

Ongoing Trials Explore Potential Benefits of Transradial PCI

November 08, 2011

News Industry News

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

November 07, 2011

News Conference News

BRAVO: Fewer Adverse Events with Bivalirudin vs. Heparin After Aortic Valvuloplasty

November 07, 2011

News Daily News

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

L.A. McKeown

November 01, 2011

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Daily News

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Yael L. Maxwell

October 13, 2011

News Daily News

In-hospital Bleeding after Primary PCI Increases Long-term Mortality

October 10, 2011

News Daily News

Same-Day Discharge Does Not Affect Death, Rehospitalization Risk After PCI

L.A. McKeown

October 04, 2011

News Daily News

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Leah Lawrence

September 29, 2011

News Daily News

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Jason Kahn

July 18, 2011

News Daily News

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Caitlin E. Cox

July 08, 2011

News Daily News

Bleeding in ACS Patients Takes Center Stage in ESC Position Paper

July 05, 2011

News Daily News

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Caitlin E. Cox

June 24, 2011

News Daily News

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

June 15, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

RESOLUTE All Comers Looks at Simple, Complex Cases in Comparing ZES, EES

L.A. McKeown

June 10, 2011

News Daily News

Syntax Score Predicts 1-Year Risk in ACS Patients

June 06, 2011

News Daily News

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

May 31, 2011

Advertisement

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

Ongoing Trials Explore Potential Benefits of Transradial PCI

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

BRAVO: Fewer Adverse Events with Bivalirudin vs. Heparin After Aortic Valvuloplasty

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

In-hospital Bleeding after Primary PCI Increases Long-term Mortality

Same-Day Discharge Does Not Affect Death, Rehospitalization Risk After PCI

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Bleeding in ACS Patients Takes Center Stage in ESC Position Paper

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

RESOLUTE All Comers Looks at Simple, Complex Cases in Comparing ZES, EES

Syntax Score Predicts 1-Year Risk in ACS Patients

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content